Thyroid nodules: how to assess the risk of malignancy?

被引：0
|
作者：
Cao, C. Do [1 ]
Ladsous, M. [1 ,2 ]
机构：
[1] CHRU Lille, Hop Claude Huriez, Serv Endocrinol, Lille, France
[2] Ctr Hosp Valenciennes, Serv Endocrinol, Valenciennes, France
来源：
CORRESPONDANCES EN METABOLISMES HORMONES DIABETES ET NUTRITION | 2019年 / 23卷 / 4-5期
关键词：
Thyroid nodule; Thyroid ultrasound; Thyroid cytology; Indeterminate cytology; Molecular markers; ASSOCIATION GUIDELINES; MANAGEMENT; SYSTEM;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
About 90 to 95% of thyroid nodules are benign and will required a basic follow-up. Ultrasound evaluation and cytological analysis for selected nodules, with formal reports made according to respective EU-TIRADS (European -Thyroid Imaging Reporting and Data System) classification and Bethesda system, can provide a quantification of malignancy risk and allow to adjust clinical and sonographic monitoring and to elaborate surgical treatment. In case of non-diagnostic (Bethesda 1) or indeterminate (Bethesda III and IV) cytologie one has to discuss reassessment and follow-up, and second line tools like elastography, scintiscan imaging and cytological molecular markers, if cost-effective.
引用
下载
收藏
页码：110 / 115
页数：6
相关论文
共 50 条
  • [1] Risk of malignancy in nonpaplable thyroid nodules
    Pacella, CM
    Papini, E
    Bianchini, A
    Guglielmi, F
    Pacella, S
    Crescenzi, A
    RADIOLOGY, 2000, 217 : 515 - 515
  • [2] RISK OF MALIGNANCY IN "HOT" THYROID NODULES RESPONSE
    Gharib, Hossein
    Papini, Enrico
    Paschke, Ralf
    ENDOCRINE PRACTICE, 2011, 17 (01) : 151 - 152
  • [3] The Risk of Malignancy in Cytologically Indeterminate Thyroid Nodules
    Jones, O.
    Blackabey, V.
    Bhat, N.
    BRITISH JOURNAL OF SURGERY, 2021, 108
  • [4] PREOPERATIVE PREDICTION OF THE RISK OF MALIGNANCY IN THYROID NODULES
    Kunz, Walter
    Mismar, Ayman
    Wille, George
    Ahmad, Rohana
    Materazzi, Gabriele
    Miccoli, Paolo
    ACTA MEDICA MEDITERRANEA, 2014, 30 (02): : 329 - 334
  • [5] Ultrasonographic risk factors of malignancy in thyroid nodules
    Rios, A.
    Torregrosa, B.
    Rodriguez, J. M.
    Rodriguez, D.
    Cepero, A.
    Abellan, M. D.
    Torregrosa, N. M.
    Hernandez, A. M.
    Parrilla, P.
    LANGENBECKS ARCHIVES OF SURGERY, 2016, 401 (06) : 839 - 849
  • [6] Thyroid nodules: evaluation of risk factors for malignancy
    Wemeau, Jean-Louis
    Do Cao, Christine
    Ladsous, Miriam
    Leteurtre, Emmanuelle
    BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 2017, 201 (4-6): : 681 - 697
  • [7] Ultrasonographic risk factors of malignancy in thyroid nodules
    A Rios
    B. Torregrosa
    J. M. Rodríguez
    D. Rodríguez
    A. Cepero
    M. D. Abellán
    N. M. Torregrosa
    A. M. Hernández
    P. Parrilla
    Langenbeck's Archives of Surgery, 2016, 401 : 839 - 849
  • [8] Retrospective Evaluation of Ultrasound Features of Thyroid Nodules to Assess Malignancy Risk: A Step Toward TIRADS
    Zayadeen, Adnan R.
    Abu-Yousef, Monzer
    Berbaum, Kevin
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2016, 207 (03) : 460 - 469
  • [9] THYROID NODULES AND THYROID MALIGNANCY - RISK INVOLVED IN DELAYED SURGERY
    BOWENS, OM
    VANDER, JB
    ANNALS OF INTERNAL MEDICINE, 1962, 57 (02) : 245 - +
  • [10] Thyroid Nodule Characterization: How to Assess the Malignancy Risk. Update of the Literature
    Fresilli, Daniele
    David, Emanuele
    Pacini, Patrizia
    Del Gaudio, Giovanni
    Dolcetti, Vincenzo
    Lucarelli, Giuseppe Tiziano
    Di Leo, Nicola
    Bellini, Maria Irene
    D'Andrea, Vito
    Sorrenti, Salvatore
    Mascagni, Domenico
    Biffoni, Marco
    Durante, Cosimo
    Grani, Giorgio
    De Vincentis, Giuseppe
    Cantisani, Vito
    DIAGNOSTICS, 2021, 11 (08)
12345